Long-term effects of ezetimibe + statin (atorvastatin or rosuvastatin) combination therapy and double-dose statin therapy on low-density lipoprotein cholesterol in patients with coronary artery disease and hyperlipidaemia refractory to standard therapy
Latest Information Update: 26 Nov 2012
At a glance
- Drugs Ezetimibe (Primary) ; Atorvastatin; Rosuvastatin
- Indications Coronary artery disease; Hyperlipidaemia
- Focus Pharmacodynamics; Therapeutic Use
- 26 Nov 2012 New trial record
- 07 Nov 2012 Results presented at the 85th Annual Scientific Sessions of the American Heart Association.